Keyword: Par Pharmaceutical
News
05.01.2023
-
Novartis has agreed to pay a total of $245 million to settle lawsuits filed by direct purchasers, indirect purchasers and retailers accusing it of colluding with Par...
News
13.07.2015
- In another move to sharpen its focus on oncology, diabetes and respiratory disorders, AstraZeneca has announced it is selling all non-US rights for Entocort, a treatment for Crohn...
News
24.07.2013
- A U.S. Supreme Court ruling giving regulators the right to sue drugmakers for agreements that delay sale of cheaper generic pharmaceuticals should deter some of the most egregious...
News
23.03.2013
- The U.S. Supreme Court will hear arguments on Monday over whether big drug companies can settle patent litigation with generic rivals by making deals to keep cheaper products off...
News
05.03.2013
- Par Pharmaceutical has agreed to pay $45 million to settle federal criminal and civil probes over its marketing and sale of a drug to treat appetite loss in AIDS patients, a...
News
05.10.2012
- The Federal Trade Commission asked the US Supreme Court on Thursday to take up its fight against deals between brand-name drug companies and generic firms which they say delay the...
News
02.08.2012
- Laboratory Corp of America Holdings said it has no knowledge of any plans for a leveraged buyout of the company after a report that a private equity consortium was targeting the...
News
21.07.2012
- Aggressive consolidation among U.S. and European generic drugmakers is putting pressure on smaller competitors in the industry, whose best hope of surviving a brewing price war may...
